• GMP
• Reviews
• Subscription
• Allotment

Mankind Pharma IPO Particulars & Guidance @ Chanakyanipothi.com, India`s Oldest & the most Trusted Investment website for coming up IPOs. Operational since 8th December 1999, this is the Only Investment website in India, which has successfully completed 23 Years.

Mankind IPO listing at which price? The scrip will list on 9th May 2023. The grey market of the IPO witnessed sharp volatility. At one time the GMP had declined to Zero and there were no trades seen and then suddenly the GMP shot up to Rs. 73 and gradually improved to current level of Rs. 100/103. However, the traders show complete uncertainty about listing price. The way the promoters are Expert & energetic about the marketing, promotions and new launches, we expect positive listing, not just Rs. 1200, but there are all chances that on listing day, the scrip moves up to Rs. 1400 and yet there are large number of investors and traders who are skeptical of listing. They fear negative listing.
Actual Listing: The scrip listed at Rs. 1300 and during the intraday, it moved up to Rs. 1393.65

Who are the promoters of Mankind Pharma?
RAMESH JUNEJA, RAJEEV JUNEJA, SHEETAL ARORA, RAMESH JUNEJA FAMILY TRUST, RAJEEV JUNEJA FAMILY TRUST AND PREM SHEETAL FAMILY TRUST

Mankind Pharma IPO Particulars & Guidance
Very Elaborate Business Information: 

Mankind Pharma is India’s fourth largest pharmaceutical company in terms of Domestic Sales and second largest in terms of sales volume for the Financial Year 2022. It is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It is focused on the domestic market, as a result of which its revenue from operations in India contributed to 97.60% of its total revenue from operations for the Financial Year 2022, which was one of the
highest among peers identified by IQVIA.
It has primarily grown organically and are the youngest company among the five largest pharmaceutical companies in India, in terms of Domestic Sales in the Financial Year 2022.It operates at the intersection of the Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices and has an established track record of building and scaling brands in-house. It has created 36 brands in its pharmaceutical business that have each achieved over Rs 500.00 million in Domestic Sales in the Financial Year 2022.

It has one of the largest distribution networks of medical representatives in the Indian pharmaceutical market and over 80% of doctors in India prescribed its formulations during the Financial Year 2022, which has assisted it in establishing its brands in India. Its brands have enabled it to consistently generate the highest share of drug prescriptions in the IPM over the last five years. Further, in its Covered Markets, it was ranked second by market share for the Financial Year 2022.

Mankind has experienced sustained growth and have consistently outperformed the growth of the IPM. Between the Financial Years 2020 and 2022, its Domestic Sales grew at a CAGR of approximately 16% from approximately Rs 60,647 million to approximately Rs 82,198 million, which is approximately 1.5 times that of the IPM, which grew at a CAGR of approximately 11%.
Between the Financial Years 2020 and 2022, its Domestic Sales had the fastest growth (at a CAGR of
approximately 16%) among the 10 largest corporates in the IPM by Domestic Sales. Its Domestic Sales ranking in the IPM improved from 8th in the Financial Year 2012 to 4th in the Financial Year 2022
Its consistent growth has been backed by its capital efficiency, and it had RoCE of 35.86%, 30.41% and 25.50% for the Financial Years 2020, 2021 and 2022, respectively.

Mankind Pharma is present in several acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins/minerals/nutrients and respiratory.

The company has made efforts to establish “Mankind” as a well-recognized brand in India. It has a demonstrated track record of creating brands with Domestic Sales of over Rs 1.00 billion and had the third highest number of such brands for any company in the IPM as of March 31, 2022.

Mankind has a pan-India marketing presence, with a field force of 11,196 medical representatives and 3,195 field managers, as of March 31, 2022. It has also established a significant distribution network in India, and, during the Financial Year 2022, it sold its products to over 11,000 stockists and engaged with 75 C&F agents.

The company operates 23 manufacturing facilities across India and had 2,181 manufacturing personnel as of March 31, 2022.
Its formulations manufacturing facilities have a total installed capacity of 40.77 billion units across a wide range of dosage forms including tablets, capsules, syrups, vials, ampoules, blow fill seal, soft and hard gels, eye drops, creams, contraceptives and other over-the-counter products, as of March 31, 2022. Several of the facilities have obtained approvals or certifications from, and are subject to inspections by, a range of regulatory bodies including the CDSCO and the USFDA.

Through its R&D capabilities, it has developed a portfolio of differentiated products across several therapeutic areas. As of March 31, 2022, the Company had a team of over 600 scientists and a dedicated in-house R&D center with three units located in IMT Manesar, Gurugram, Haryana. One unit of
this R&D center is recognized by the DSIR, and one unit is in compliance with WHO GMP and has been inspected by the USFDA.

For more information, click www.mankindpharma.com
Mankind Pharma IPO DRHP

What are the Objects of Mankind Pharma IPO?
This is only an offer for sale of Shares by the selling shareholders.

Mankind Pharma IPO Particulars & Guidance

What is the latest Grey market premium and Subject to rates for Mankind Pharma IPO?
Click latest updates. 
>>Go to SME IPOs Section: Click
>>Get Good Staff or Job, Click: Staffavailable.com
>>Interested in Used Automobiles or vintage cars? Click: BigGaddi.com
>>Get solid Guidance on Mutual fund Investments, Click: ChanakyaMFGuidance.com
>>Study Stock Research Reports, Click: AnalysisLibrary.com
>>Interested in Crossword Puzzles? Click: Magajmari.com